× Medicines Discovery Catapult

Marcus joined the Medicines Discovery Catapult as Chief Operating Officer in April 2017 and assumes overall responsibility for the operational functions, including Finance, HR, Facilities, Procurement, IT and Legal (IP).

Marcus has a strong technical and commercial background, having previously worked in start-up and small biotech companies for nearly 20 years. Previously, Marcus was CEO of Nanotether Discovery Sciences, a start-up company developing a novel drug discovery technology platform. Prior to this he held a number of management positions in diagnostics and medtech companies, leading multidisciplinary teams across genomics, informatics and proteomics.